Treatment of donor mice with an αβ T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts

Blood

Volumn 87, Issue 12, 1996, Pages 5355-5369

  Drobyski, William R ^a,b   Majewski, David ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H57 597; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CLONAL ANERGY; CONTROLLED STUDY; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CLONAL ANERGY; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; GRAFT VS HOST DISEASE; H-2 ANTIGENS; HISTOCOMPATIBILITY; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED AKR; MICE, INBRED C57BL; MICE, INBRED DBA; RADIATION CHIMERA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029954330     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5355.bloodjournal87125355     Document Type: Article

References (38)

1. Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds): Graft-Versus-Host Disease. New York, NY, Marcel Dekker, 1990
2. Vallera DA, Youle RJ, Neville DM, Kersey JH: Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-versus-host disease by pretreatment of donor cells with monoclonal anti-Thy 1.2 coupled to the toxin ricin. J Exp Med 155:949, 1982
3. Waldmann H, Hale G, Cividalli G, Weshler Z, Manor D, Rachmilewitz EA, Polliak A, Or R, Weiss L, Samuel S, Brantbar C, Slavin S: Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-I). Lancet 1:483, 1984
4. Blazar BR, Taylor PA, Vallera DA: In vivo or in vitro anti-CD3ε chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice. J Immunol 152:3665, 1994
5. 2 fragments in vivo to modulate graft -versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J Immunol 154:5542, 1995
6. Maeda T, Eto M, Lin T, Nishimura Y, Kong Y-Y, Nomoto K, Nomoto K: Amelioration of acute graft-versus-host disease and reestablishment of tolerance by short-term treatment with an anti-TCR antibody. J Immunol 153:4311, 1994
7. Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA: Nonmitogenic anti-CD3 F(ab′)2 fragments prevents lethal murine graft-versus-host disease induced across the major histocompatibility barrier. J Immunol 150:265, 1993
8. Jenkins MK, Chen C, Jung G, Mueller DL, Schwartz RH: Inhibition of antigen-specific proliferation of type I murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 144:16, 1990
9. Nau GJ, Moldwin RL, Lancki DW, Kim D-K, Fitch FW: Inhibition of IL-2 driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody. J Immunol 139:114, 1987
10. Tomonari K: Down-regulation of the T cell receptor by a mitogenic anti-Thy-1 antibody. Eur J Immunol 18:179, 1988
11. Kubo RT, Born W, Kappler JW, Marrack P, Pigeon M: Characterization of a monoclonal antibody which detects all murine T cell receptors-αβ. J Immunol 142:2736, 1989
12. Koo GC, Peppard JR: Establishment of monoclonal anti-NK 1.1 antibody. Hybridoma 3:301, 1984
13. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA: Identification of a MoAb specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 84:1374, 1987
14. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. New York, NY, John Wiley and Sons, 1994, p 4.2.1
15. Struhl K. A rapid method for creating recombinant DNA molecules. Biotechnique 3:452, 1985
16. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MK: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12:7035, 1984
17. Johnson BD, Truitt RL: Selective depletion of donor NK cells in vivo decreases graft-vs-host disease without loss of graft-vs-leukemia reactivity after MH-matched bone marrow transplantation. Transplantation 54:104, 1992
18. Maier T, Holda JH, Claman HN: Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. J Immunol 135:1644, 1985
19. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE: Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 84:3540, 1994
20. Truitt RL, Johnson BD, McCabe C, Weiler MB: Graft-versus-leukemia, in Burakoff S, Ferrara JLM (eds): Graft-vs-Host Disease. New York, NY, Marcell-Dekker (in press)
21. 2 fragments induce a selective T-helper dysfunction. J Immunol 147:2088, 1991
22. + T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant 8:51, 1991
23. + lymphoid engraftment. J Immunol 152:1004, 1994
24. Scott DE, Gause WC, Finkelman FD, Steinberg AD: Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J Immunol 2183, 1990
25. Schwinzer R, Franklin RA, Domenico J, Retz H, Gelfand EW: Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells. J Immunol 148:1322, 1992
26. Schwinzer R, Sommermeyer H, Schutt HJ, Schmidt RE, Wonigeit K: Activation of human thymocytes by antibodies to the CD3/T cell receptor complex: Triggering of different epitopes results in different signals. Cell Immunol 136:318, 1991
27. Finkel TH, Marrack P, Kappler JW, Kubo RJ, Combier CJ: T cell receptor αβ and CD3 transduce different signals in immature T cells: Implication for selection and tolerance. J Immunol 42:3006, 1989
28. Kang SM, Beverly B, Tran A-C, Brorson K, Schwartz RH, Lenardo MJ: Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134, 1992
29. Becker JC, Brabletz T, Kirchner T, Conrad CT, Brocker E-B, Reisfeld RA: Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci USA 92:2375, 1995
30. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH: Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci USA 84:5409, 1987
31. Gajewski TF, Qian D, Fields P, Fitch FW: Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci USA 91:38, 1994
32. Cho EA, Riley MP, Sillman AL, Quill H: Altered protein tyrosine phosphorylation in anergic Th1 cells. J Immunol 151:20, 1993
33. Hirsch R, Eckhaus M, Auchincloss H Jr, Sachs DH, Bluestone JA: Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. J Immunol 140:3766, 1988
34. Strober S, Palathumpat V, Schwardron P, Hertel-Wulff B: Cloned natural suppressor cells prevent lethal graft-vs-host disease. J Immunol 138:699, 1987
35. Hertel-Wulff B, Okada S, Oseroff A, Strober S: In vitro propagation and cloning of murine natural suppressor (NS) cells. J Immunol 133:2791, 1984
36. Sykes M, Sharabi Y, Sachs DH: Natural suppressor cells in spleens of irradiated bone marrow reconstituted mice and normal bone marrow: Lack of SCA-1 expression and enrichment by depletion of MAC-1 positive cells. Cell Immunol 127:260, 1990
37. Quill H, Schwartz RH: Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 138:3704, 1987
38. Mysliwietz J, Thierfelder S: Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient. Blood 80:2661, 1992